Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950123-08-002693
Filing Date
2008-03-07
Accepted
2008-03-07 16:45:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D y50640qsc13dza.htm SC 13D/A 22218
  Complete submission text file 0000950123-08-002693.txt   23971
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filed by) CIK: 0000816284 (see all company filings)

EIN.: 222711928 | State of Incorp.: DE | Fiscal Year End: 0501
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 2525 28TH STREET BOULDER CO 80301 720 564 9100
PHARMION CORP (Subject) CIK: 0001203866 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79338 | Film No.: 08674736
SIC: 2834 Pharmaceutical Preparations